The NANOTUMOR consortium - Towards the Tumor Cell Atlas.

Cancer Cellular Imaging Electron & Light Microscopy Metastasis Oncology

Journal

Biology of the cell
ISSN: 1768-322X
Titre abrégé: Biol Cell
Pays: England
ID NLM: 8108529

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 03 11 2020
accepted: 25 01 2021
pubmed: 9 2 2021
medline: 23 11 2021
entrez: 8 2 2021
Statut: ppublish

Résumé

Cancer is a multi-step disease where an initial tumour progresses through critical steps shaping, in most cases, life-threatening secondary foci called metastases. The oncogenic cascade involves genetic, epigenetic, signalling pathways, intracellular trafficking and/or metabolic alterations within cancer cells. In addition, pre-malignant and malignant cells orchestrate complex and dynamic interactions with non-malignant cells and acellular matricial components or secreted factors within the tumour microenvironment that is instrumental in the progression of the disease. As our aptitude to effectively treat cancer mostly depends on our ability to decipher, properly diagnose and impede cancer progression and metastasis formation, full characterisation of molecular complexes and cellular processes at play along the metastasis cascade is crucial. For many years, the scientific community lacked adapted imaging and molecular technologies to accurately dissect, at the highest resolution possible, tumour and stromal cells behaviour within their natural microenvironment. In that context, the NANOTUMOR consortium is a French national multi-disciplinary workforce which aims at a providing a multi-scale characterisation of the oncogenic cascade, from the atomic level to the dynamic organisation of the cell in response to genetic mutations, environmental changes or epigenetic modifications. Ultimately, this program aims at identifying new therapeutic targets using innovative drug design.

Identifiants

pubmed: 33554340
doi: 10.1111/boc.202000135
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

272-280

Informations de copyright

© 2021 Société Française des Microscopies and Société de Biologie Cellulaire de France. Published by John Wiley & Sons Ltd.

Références

Bertolin, G., Sizaire, F., Herbomel, G., Reboutier, D., Prigent, C., & Tramier, M. (2016). A FRET biosensor reveals spatiotemporal activation and functions of aurora kinase A in living cells. Nat. Commun., 7(1), 12674. https://doi.org/10.1038/ncomms12674
Branon, T. C., Bosch, J. A., Sanchez, A. D., Udeshi, N. D., Svinkina, T., Carr, S. A., Feldman, J. L., Perrimon, N., & Ting, A. Y. (2018). Efficient proximity labeling in living cells and organisms with TurboID. Nat. Biotechnol., 36(9), 880-887. https://doi.org/10.1038/nbt.4201
Charafe-Jauffret, E., Ginestier, C., Bertucci, F., Cabaud, O., Wicinski, J., Finetti, P., Josselin, E., Adelaide, J., Nguyen, T. T., Monville, F., Jacquemier, J., Thomassin-Piana, J., Pinna, G., Jalaguier, A., Lambaudie, E., Houvenaeghel, G., Xerri, L., Harel-Bellan, A., Chaffanet, M., … Birnbaum, D. (2013). ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program. Cancer Res., 73(24), 7290-7300. https://doi.org/10.1158/0008-5472.CAN-12-4704
Geladaki, A., Kočevar Britovšek, N., Breckels, L. M., Smith, T. S., Vennard, O. L., Mulvey, C. M., Crook, O. M., Gatto, L., & Lilley, K. S. (2019). Combining LOPIT with differential ultracentrifugation for high-resolution spatial proteomics. Nat. Commun., 10(1), 331. https://doi.org/10.1038/s41467-018-08191-w
Gensbittel, V., Kräter, M., Harlepp, S., Busnelli, I., Guck, J., & Goetz, J. G. (2020). Mechanical adaptability of tumor cells in metastasis. Dev. Cell, 2020, 1-16. https://doi.org/10.1016/j.devcel.2020.10.011
Ghoroghi, S., Mary, B., Larnicol, A., Asokan, N., Klein, A., Osmani, N., Busnelli, I., Delalande, F., Paul, N., Halary, S., Gros, F., Fouillen, L., Haeberle, A.-M., Royer, C., Spiegelhalter, C., André-Grégoire, G., Mittelheisser, V., Detappe, A., Murphy, K., … Hyenne, V. (2021). Ral GTPases promote breast cancer metastasis by controlling biogenesis and organ targeting of exosomes. ELife, 10. https://doi.org/10.7554/eLife.61539
Jiao, Y., Shi, C., Edil, B. H., de Wilde, R. F., Klimstra, D. S., Maitra, A., Schulick, R. D., Tang, L. H., Wolfgang, C. L., Choti, M. A., Velculescu, V. E., Diaz, L. A., Vogelstein, B., Kinzler, K. W., Hruban, R. H., & Papadopoulos, N. (2011). DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science, 331(6021), 1199-1203. https://doi.org/10.1126/science.1200609
Jones, P. A., & Baylin, S. B. (2002). The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3(6), 415-428. https://doi.org/10.1038/nrg816
Jones, P. A., & Laird, P. W. (1999). Cancer-epigenetics comes of age. Nat. Genet., 21(2), 163-167. https://doi.org/10.1038/5947
Kadoch, C., & Crabtree, G. R. (2015). Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics. Sci. Adv., 1(5), e1500447. https://doi.org/10.1126/sciadv.1500447
Karreman, M. A., Mercier, L., Schieber, N. L., Solecki, G., Allio, G., Winkler, F., Ruthensteiner, B., Goetz, J. G., & Schwab, Y. (2016). Fast and precise targeting of single tumor cells in vivo by multimodal correlative microscopy. J. Cell Sci., 129(2), 444-456. https://doi.org/10.1242/jcs.181842
Mazuc, E., Guglielmi, L., Bec, N., Parez, V., Hahn, C. S., Mollevi, C., Parrinello, H., Desvignes, J.-P., Larroque, C., Jupp, R., Dariavach, P., & Martineau, P. (2014). In-cell intrabody selection from a diverse human library identifies C12orf4 protein as a new player in rodent mast cell degranulation. PLoS ONE, 9(8), e104998. https://doi.org/10.1371/journal.pone.0104998
Mulvey, C. M., Breckels, L. M., Geladaki, A., Britovšek, N. K., Nightingale, D. J. H., Christoforou, A., Elzek, M., Deery, M. J., Gatto, L., & Lilley, K. S. (2017). Using hyperLOPIT to perform high-resolution mapping of the spatial proteome. Nat. Protoc., 12(6), 1110-1135. https://doi.org/10.1038/nprot.2017.026
Pu, J., Guardia, C. M., Keren-Kaplan, T., & Bonifacino, J. S. (2016). Mechanisms and functions of lysosome positioning. J. Cell Sci., 129(23), 4329-4339. https://doi.org/10.1242/jcs.196287
Rozenblatt-Rosen, O., Regev, A., Oberdoerffer, P., Nawy, T., Hupalowska, A., Rood, J. E., Ashenberg, O., Cerami, E., Coffey, R. J., Demir, E., Ding, L., Esplin, E. D., Ford, J. M., Goecks, J., Ghosh, S., Gray, J. W., Guinney, J., Hanlon, S. E., Hughes, S. K., … Zhuang, X. (2020). The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution. Cell, 181(2), 236-249. https://doi.org/10.1016/j.cell.2020.03.053
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., Hovestadt, V., Albrecht, S., Kool, M., Nantel, A., Konermann, C., Lindroth, A., Jäger, N., Rausch, T., Ryzhova, M., …Jabado, N. (2012). Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature, 482(7384), 226-231. https://doi.org/10.1038/nature10833
Spehner, D., Steyer, A. M., Bertinetti, L., Orlov, I., Benoit, L., Pernet-Gallay, K., Schertel, A., & Schultz, P. (2020). Cryo-FIB-SEM as a promising tool for localizing proteins in 3D. J. Struct. Biol., 211(1), 107528. https://doi.org/10.1016/j.jsb.2020.107528
Swinney, D. C., & Anthony, J. (2011). How were new medicines discovered? Nat. Rev. Drug Discov., 10(7), 507-519. https://doi.org/10.1038/nrd3480
van Bergeijk, P., Hoogenraad, C. C., & Kapitein, L. C. (2016). Right time, right place: probing the functions of organelle positioning. Trends Cell Biol., 26(2), 121-134. https://doi.org/10.1016/j.tcb.2015.10.001

Auteurs

Florent Colin (F)

INSERM UMR_S1109, Tumor Biomechanics Lab, Université de Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), CNRS SNC5055, Strasbourg, France.

Kristine Schauer (K)

CNRS UMR144, Molecular Mechanisms of Intracellular Transport group, Institut Curie, 75005 Paris, France, PSL Research University, Paris, France, Sorbonne Université, Paris, France, Inserm U1279, Gustave Roussy Institute, Université Paris-Saclay, Villejuif, France.

Ali Hamiche (A)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS UMR7104, INSERM U1258, Université de Strasbourg, Illkirch, France.

Pierre Martineau (P)

Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier (ICM), Montpellier, France.

Jean-Paul Borg (JP)

Aix Marseille Univ, CNRS UMR7258, INSERM UMR1068, Institut Paoli Calmettes, CRCM, Marseille, 13009, France.
Institut Universitaire de France (IUF), Paris, France.

Jan Bednar (J)

Institute for Advanced Biosciences (IAB), Université Grenoble Alpes, CNRS UMR5309, INSERM U1209, La Tronche, France.

Giulia Bertolin (G)

CNRS, Univ Rennes, IGDR (Genetics and Development Institute of Rennes), UMR 6290, Rennes, F-35000, France.

Luc Camoin (L)

Aix Marseille Univ, CNRS UMR7258, INSERM UMR1068, Institut Paoli Calmettes, CRCM, Marseille, 13009, France.

Yves Collette (Y)

Aix Marseille Univ, CNRS UMR7258, INSERM UMR1068, Institut Paoli Calmettes, CRCM, Marseille, 13009, France.

Stephan Dimitrov (S)

Institute for Advanced Biosciences (IAB), Université Grenoble Alpes, CNRS UMR5309, INSERM U1209, La Tronche, France.

Isabelle Fournier (I)

Institut Universitaire de France (IUF), Paris, France.
Univ. Lille, INSERM, CHU Lille, U1192 - Protéomique Réponse Inflammatoire Spectrométrie de Masse - PRISM, Lille, F-59000, France.

Vincent Hyenne (V)

INSERM UMR_S1109, Tumor Biomechanics Lab, Université de Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), CNRS SNC5055, Strasbourg, France.

Marco A Mendoza-Parra (MA)

UMR8030 Génomique Métabolique, Genoscope, Institut François Jacob, CEA, CNRS, University of Evry-val-d'Essonne, University Paris-Saclay, Evry, France.

Xavier Morelli (X)

Aix Marseille Univ, CNRS UMR7258, INSERM UMR1068, Institut Paoli Calmettes, CRCM, Marseille, 13009, France.

Philippe Rondé (P)

Faculté de Pharmacie, Université de Strasbourg, Illkirch, France.
CNRS UMR7021, Laboratoire de Bioimagerie et Pathologies, Illkirch, France.

Izabela Sumara (I)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS UMR7104, INSERM U1258, Université de Strasbourg, Illkirch, France.

Marc Tramier (M)

CNRS, Univ Rennes, IGDR (Genetics and Development Institute of Rennes), UMR 6290, Rennes, F-35000, France.

Patrick Schultz (P)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS UMR7104, INSERM U1258, Université de Strasbourg, Illkirch, France.

Jacky G Goetz (JG)

INSERM UMR_S1109, Tumor Biomechanics Lab, Université de Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), CNRS SNC5055, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH